Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Universal Health Services
UHS
$10.5B
| $1.52M | ﹤0.01% |
13,723
-73,971
| -84% | -$8.33M |
|
2302
Abercrombie & Fitch
ANF
$6.65B
| $1.52M | ﹤0.01% |
105,224
-172,761
| -62% | -$1.98M |
|
2303
Methode Electronics
MEI
$571M
| $1.52M | ﹤0.01% |
35,841
-181,286
| -83% | -$7.19M |
|
|
STB
2304
DELISTED
Student Transportation Inc
STB
| $1.51M | ﹤0.01% |
253,303
+215,850
| +576% | +$1.29M |
|
2305
PUT
Labcorp
LH
$27.3B
| $1.51M | ﹤0.01% |
+11,640
| New | +$1.55M |
|
|
TIG
2306
DELISTED
TiGenix American Depositary Shares
TIG
| $1.51M | ﹤0.01% |
63,377
-4,136
| -6% | -$91.5K |
|
2307
Tilly's
TLYS
$117M
| $1.51M | ﹤0.01% |
125,689
-30,877
| -20% | -$322K |
|
2308
Valvoline
VVV
$4.2B
| $1.51M | ﹤0.01% |
64,281
-273,251
| -81% | -$6.13M |
|
|
DCOM
2309
DELISTED
Dime Community Bancshares
DCOM
| $1.5M | ﹤0.01% |
70,017
-26,784
| -28% | -$528K |
|
|
TRK
2310
DELISTED
Speedway Motorsports, Inc.
TRK
| $1.5M | ﹤0.01% |
70,251
+49,965
| +246% | +$1.01M |
|
|
COL
2311
PUT
DELISTED
Rockwell Collins
COL
| $1.49M | ﹤0.01% |
+11,400
| New | +$1.38M |
|
|
HSII
2312
DELISTED
Heidrick & Struggles
HSII
| $1.49M | ﹤0.01% |
70,294
+52,872
| +303% | +$1.03M |
|
2313
Booz Allen Hamilton
BAH
$8.92B
| $1.49M | ﹤0.01% |
39,719
-86,604
| -69% | -$2.98M |
|
2314
Knowles
KN
$2.89B
| $1.49M | ﹤0.01% |
97,268
+40,164
| +70% | +$617K |
|
2315
Schwab US Large- Cap ETF
SCHX
$74B
| $1.48M | ﹤0.01% |
148,098
+49,950
| +51% | +$490K |
|
2316
Stride
LRN
$3.54B
| $1.48M | ﹤0.01% |
82,892
-136,300
| -62% | -$2.42M |
|
|
CXP
2317
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.48M | ﹤0.01% |
+67,878
| New | +$1.46M |
|
|
SRRA
2318
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.48M | ﹤0.01% |
23,800
+22,785
| +2,245% | +$1.34M |
|
2319
LCI Industries
LCII
$2.49B
| $1.47M | ﹤0.01% |
12,695
+9,894
| +353% | +$1.01M |
|
|
AZRE
2320
DELISTED
Azure Power Global Limited
AZRE
| $1.47M | ﹤0.01% |
92,366
-9,766
| -10% | -$152K |
|
2321
TTEC Holdings
TTEC
$67M
| $1.47M | ﹤0.01% |
35,131
-59,092
| -63% | -$2.39M |
|
|
ELP
2322
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $1.47M | ﹤0.01% |
413,578
-877,840
| -68% | -$3.07M |
|
2323
Smith & Wesson
SWBI
$603M
| $1.46M | ﹤0.01% |
+124,856
| New | +$1.76M |
|
2324
MannKind Corp
MNKD
$1.32B
| $1.46M | ﹤0.01% |
674,043
-148,149
| -18% | -$232K |
|
2325
PUT
Boston Scientific
BSX
$69.3B
| $1.46M | ﹤0.01% |
50,000
-300,000
| -86% | -$8.28M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.